From: Validation of a yellow fever vaccine model using data from primary vaccination in children and adults, re-vaccination and dose-response in adults and studies with immunocompromised individuals
Categorical time
Number of individuals
Average time (days)
GMT (reciprocal dilution)
PV (5–9 years)
23
2797 (2008–3285)
152
PV (> 10 years)
45
5021 (3650–5475)
100